Smith Anderson's technology transactions lawyers work with businesses to develop, protect and promote their knowledge, discoveries and innovations. Our attorneys support their clients engaged in technology-focused transactions to acquire, sell, finance, support, develop, and monetize key intellectual property assets. This includes a variety of transaction arrangements, including mergers and acquisitions, strategic licensing and technology transfer, collaboration and development agreements, partnering and alliances, sponsored research, financing and manufacturing/sourcing arrangements.
We are nationally recognized in the Licensing & Collaboration category of the 2022 LMG Life Sciences rankings, the only law firm headquartered in North Carolina to receive this honor. Additionally, Smith Anderson's technology transactions practice is routinely across the table from the largest law firms in the world, leading transactions that have received premiere awards such as the Life Science sector Deals of Distinction™ award by the Licensing Executives Society, and the LMG Life Sciences Collaboration Impact Deal of the Year award.
Our technology transactions clients range from publicly-traded companies and well-established privately-held businesses to start-ups, emerging companies and university spin outs. We provide transactional intellectual property- and technology-related counseling to clients in a wide array of industries, including: life sciences, agricultural technology, software, health care, pharmaceuticals, biotechnology, telecommunications, video games, electronics, banking, building materials, e-commerce, industrial machinery, semiconductors, energy, consumer goods and more. As a full-service firm, we also advise our clients on labor and employment matters, employee benefits, tax strategies, governmental relations, data use, privacy and cybersecurity, real estate and other business-related matters.
- Licensing and technology transfer
- Mergers and acquisitions
- Research, development and commercialization collaborations
- Partnering, strategic alliance and joint venture arrangements
- Product and intellectual property acquisitions and divestitures
- Information privacy and cybersecurity matters, including policies and procedures, breach notice and incident response, investigations and corporate transactions
- Represented a leading genome editing company in its approximately $2.7 billion research collaboration, including an upfront payment of $135 million, with a global, publicly-traded pharmaceutical company to develop and commercialize gene editing-based gene therapies for up to six targets.
- Lead counsel to a venture capital-funded genome editing company in a worldwide partnership, worth up to $1.6 billion, including an upfront payment of $105 million, with a global, publicly-traded pharmaceutical company, to develop and commercialize allogeneic chimeric antigen receptor (CAR) T cell therapies for multiple cancers. The transaction was awarded the 2016 Life Science sector Deals of Distinction™ award by the Licensing Executives Society.
- Represented a biotechnology company that develops CRISPR-engineered precision antibacterial products in an exclusive collaboration and license agreement valued at up to $818 million with a leading global pharmaceutical company to develop, manufacture and commercialize CRISPR-Cas3-enhanced bacteriophage products targeting bacterial pathogens for potential treatment of certain infections.
- Represented a venture capital-funded genome editing company in its up to $445 million comprehensive worldwide development and commercialization agreement with a leading global biopharmaceutical company to develop therapies targeting the in vivo elimination of hepatitis B virus (HBV) using a proprietary genome editing platform.
- Represented the world's largest public company provider of biopharmaceutical development services and commercial outsourcing services in a joint venture with the world's leading public company provider of diagnostic information services, to form a global clinical trials laboratory services business with annual revenues of approximately $575 million.
- Represented an international health care group and its U.S. specialty pharmaceutical company subsidiary in obtaining multinational license rights to three cardiovascular drugs from a large public pharmaceutical company for $264 million in cash at closing, up to $480 million in milestone and royalty payments, and the assumption of up to $50 million in milestone payment obligations.
- Dozens of worldwide and territory-specific pharmaceutical, biologic and medical device research, development, license, collaboration and acquisition agreements, for therapeutic areas ranging from immuno-oncology to CNS disorders, dermatology, ophthalmology, cardiovascular, rare disease, oncology, vaccines, and others.
- Lead counsel to a venture capital-funded AgTech company in a license agreement of next-generation genome editing technology from a university to advance innovation in agriculture, and a related $100 million strategic alliance with a global, publicly-traded agrochemical and agricultural biotechnology company, to progress agriculture research by leveraging gene editing technology.
- Over 200 AgTech research, development, license, acquisition and collaboration agreements, totaling in excess of $2 billion in cumulative value plus royalties, including over 50 transactions involving five of the six largest agriculture companies in the world.
- Represented a leading genome editing company in over a dozen research, collaboration, licensing and development agreements ranging from human therapeutics to row plant crop applications and specialty plant crop applications.
- Represented a venture capital funded agricultural biotechnology company in its $400 million acquisition by a public company buyer.
- Represented a global solid state LED lighting and semiconductor manufacturing company in connection with its $850 million sale of assets to a publicly traded German semiconductor company. The transaction was terminated before completion due to regulatory considerations.
- Advised a worldwide interactive entertainment and gaming company in the sale of a game franchise to a global computer software company and assisted in the development of an innovative licensing model for the client's video game development software.
- Advised a semiconductor and global solid state LED lighting manufacturing company in an agreement to purchase the assets of the radio frequency (RF) power business of a publicly traded semiconductor company for €345 million in cash.
- Represented a NYSE-listed energy company in a strategic alliance with an on-site power generation systems company to integrate an energy platform with smart storage solutions, including an initial 50 megawatt project involving distributed generation systems at over 150 sites.
- Advised a worldwide interactive entertainment and gaming company in its $1.25 billion investment from multiple investment firms and individuals at the forefront of technology and entertainment.
- Advised a semiconductor and LED company on the divestiture of its lighting products business unit for an initial cash payment of $225 million plus the potential to receive an earn-out payment based on the business’s post-closing performance.
- Assisted a leading corporate travel management firm in the U.S. with drafting and negotiation of a services agreement with a creative consulting firm for a brand identity refresh and related website redesign and development services.
- Representation of a leading provider of wireless transmission systems in its divestiture of an integrated communications network management software platform and related assets to a network management software company.
- Represented a leading fuel pump supplier in establishing a technology, sales and service partnership with a leading payment system supplier to develop next-generation payment and media technologies for the retail petroleum industry.
- Conducted training sessions for the legal department of one of the world’s largest software and technology service providers, providing negotiation and risk allocation strategies for the company’s technology license and services arrangements, covering complex indemnity provisions, license provisions and related risk allocation issues.
- Represented university spin-outs in licensing foundational technology from universities such as Harvard University/Massachusetts General Hospital, MIT, Caltech, Columbia University, Duke University, Johns Hopkins University, University of California System, Duquesne University, University of North Carolina at Chapel Hill, North Carolina State University, East Carolina University, Dartmouth College, University of Pennsylvania, University of Virginia and Virginia Tech, among others.
- Practice ContactAttorney
- Practice ContactAttorney
- Firm Chair
- LMG Life SciencesNews
- Smith Anderson Gains Four More Chambers Ranked Practitioners Across Practices in 2023 Chambers USA GuideChambers USARecognition
- Gov. Cooper Appoints Smith Anderson Attorney Phil Cardinale to N.C. Board of Science, Technology and InnovationNews
- LMG Life SciencesRecognition
- Chambers USAAlert
- Chambers USAAlert
- U.S. News & World Report and Best Lawyers® “Best Law Firms”
- Smith Anderson Attorney Appointed Vice Chair of ABA Intellectual Property Section’s Trademark Litigation Committee
- Chambers USAAlert
- American Bar Association Intellectual Property Law Section Honors Phil Cardinale with Leadership Award
- Smith Anderson Ranks Nationally and Regionally in Practice Areas by U.S. News and Best Lawyers® 2019 “Best Law Firms”U.S. News & World Report and Best Lawyers® “Best Law Firms”
- Triangle Business Journal Consults with Trade Secrets Attorney Zeb Anderson on the Growing Upsurge in Trade Secrets Lawsuits in NCTriangle Business Journal
- Chambers USAAlert
- Smith Anderson Strengthens its National Technology Transactions Practice with the Addition of Darrell Fruth
- European Union Delegation Visits Smith Anderson to Discuss Foreign Direct Investment in the United States
- Council for Entrepreneurial Development, Website
- BTI Industry Power Rankings
- Chambers USAAlert
- Recognized Nationally for Best-in-Class Client Service, Smith Anderson is Named to the BTI Client Service A-Team
- Smith Anderson Advises Chiesi in Transaction to Acquire Three Cardiovascular Hospital Products for up to $792 Million
- Chambers USAAlert
- Smith Anderson Advises Chiesi in Agreement to Acquire Three Cardiovascular Hospital Products for up to $792 Million
- 2016 U.S. News & World Report and Best Lawyers® “Best Law Firms” Recognizes Smith Anderson in 38 Practice Categories and Awards a National RatingAlert
- Mike Weddington Appointed to North Carolina Bar Association Judicial Performance Evaluation Committee
- Smith Anderson’s Executive Roundtable Series Addresses How Companies can Prepare for and Respond to a Data Breach
- Blake Simpson Fricks Profiled in Walter Magazine for her Role as Director of Development for Neighbor to Neighbor
- Governor McCrory, Mike Mitchell and the North Carolina Business Committee for Education Announce the Teachers @ Work Initiative
- Mike Mitchell Named Vice Chair of Board of Directors for North Carolina Business Committee for Education
- John Therien and Robert Rehm Present at North Carolina Central University School of Law Biotechnology and Pharmaceutical Law Review Symposium
- "Intellectual Property: Fueling the Health Care Reform Engine" article, co-authored by Freddie Zufelt and Robert Rehm, to Be Published in Wake Forest Journal of Business and Intellectual Property Law
- Robert Rehm Moderates Panel Discussion at Duke Law's 10th Annual "Hot Topics in Intellectual Property" Symposium
- Robert Rehm Teaches Course on Intellectual Property Transactions at Campbell University School of Law
- Robert Rehm's Article "Navigating the Open-Source Minefield: What's a Business To Do?" Published in Wake Forest Intellectual Property Law Journal
- Blake Simpson Fricks and Kelli Ovies Present Trademark Law Class at University of North Carolina School of Law
- Robert Rehm Presents at North Carolina Central University School of Law Biotechnology and Pharmaceutical Law Institute and Law Review Symposium
- Robert Rehm Moderates Panel Discussion at Duke Law's 9th Annual "Hot Topics in Intellectual Property" Symposium
- Smith Anderson Lawyers Participate in “Intellectual Property and Cyberlaw Society” Panel at Duke Law School
Publications & Alerts
- My Company Can be Sued Where?: Supreme Court Resolves Some Questions of Where Businesses May Be Sued for Patent Infringement but Leaves Others UnsettledSeed World
- Supreme Court Considers Impact of TTAB "Likelihood of Confusion" Finding on Trademark Infringement Litigation
- U.S. Supreme Court Relaxes Standard For Prevailing Parties To Recover Attorneys’ Fees In Patent Infringement Litigation
- Fourth Circuit Clarifies the Role of the District Court in a Trademark Civil Action Following a Proceeding Before the Trademark Trial and Appeal Board
Events & Programming
- The Umstead (Ballroom 1): 100 Woodland Pond Drive, Cary, N.C. 27513Event